Talphera (TLPH) Invested Capital (2010 - 2023)
Talphera (TLPH) posted Invested Capital of $14.1 million for Q4 2023, down 22.95% on a QoQ basis from $18.3 million in Q3 2023, and down 48.1% year-over-year from $27.2 million in Q4 2022.
Analysis
Talphera (TLPH) Invested Capital (2010 - 2023) Analysis & Trends
Talphera has reported Invested Capital for 14 years, with the latest figure at $14.1 million in Q4 2023.
- On a quarterly basis, Invested Capital fell 48.1% year-over-year to $14.1 million in Q4 2023; TTM through Dec 2023 was $14.1 million, a 48.1% decrease from a year earlier, with the FY2023 full-year figure at $14.1 million, down 48.1% from the prior year.
- Invested Capital was $14.1 million for Q4 2023 at Talphera, down from $18.3 million in the prior quarter.
- The five-year high for Invested Capital was $43.0 million in Q2 2022, with the low at -$34.1 million in Q3 2020.
- Average Invested Capital over 5 years is -$3.8 million, with a median of -$5.8 million recorded in 2019.
- The sharpest annual moves came in 2020 and 2022: Invested Capital plunged 1483.47% in 2020, then soared 341.05% in 2022.
- Over 5 years, Invested Capital stood at -$16.3 million in 2019, then tumbled by 108.19% to -$33.9 million in 2020, then soared by 34.79% to -$22.1 million in 2021, then soared by 223.03% to $27.2 million in 2022, then sank by 48.1% to $14.1 million in 2023.
- The last three Invested Capital figures came in at $14.1 million (Q4 2023), $18.3 million (Q3 2023), and $10.4 million (Q2 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 74.44 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 40.49 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 33.70 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 7.35 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 26.94 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 14.11 Mn |
| Sep 30, 2023 | 18.31 Mn |
| Jun 30, 2023 | 10.42 Mn |
| Mar 31, 2023 | 20.86 Mn |
| Dec 31, 2022 | 27.18 Mn |
| Sep 30, 2022 | 35.11 Mn |
| Jun 30, 2022 | 43.03 Mn |
| Mar 31, 2022 | -26.42 Mn |
| Dec 31, 2021 | -22.09 Mn |
| Sep 30, 2021 | -27.29 Mn |
| Jun 30, 2021 | -17.85 Mn |
| Mar 31, 2021 | -7.30 Mn |
| Dec 31, 2020 | -33.88 Mn |
| Sep 30, 2020 | -34.14 Mn |
| Jun 30, 2020 | -34.10 Mn |
| Mar 31, 2020 | -29.54 Mn |
| Dec 31, 2019 | -16.27 Mn |
| Sep 30, 2019 | -4.27 Mn |
| Jun 30, 2019 | 5.35 Mn |
| Mar 31, 2019 | 2.14 Mn |